Inventor · disambiguated record
Shi-Xian Deng
Also filed as: DENG SHI-XIAN
29 granted patents·16 pending applications·81 citations·filing 2003–2024
95Inventor score
Top patents by PatentIndex Score
45 records- 0195US9650383B2Aldose reductase inhibitors and uses thereofUNIV COLUMBIA·Filed 2014·Granted May 16, 2017·18 cites·24 claims
- 0295US8916563B2Aldose reductase inhibitors and uses thereofUNIV COLUMBIA·Filed 2013·Granted Dec 23, 2014·22 cites·6 claims
- 0394US10052324B2Aldose reductase inhibitors and uses thereofUNIV COLUMBIA·Filed 2017·Granted Aug 21, 2018·11 cites·16 claims
- 0489US8318156B2Anti-cocaine compositions and treatmentLANDRY DONALD W·Filed 2007·Granted Nov 27, 2012·11 cites·20 claims
- 0584US9402826B2Neuronal pain pathway modulatorsUNIV COLUMBIA·Filed 2014·Granted Aug 2, 2016·3 cites·2 claims
- 0684US8846742B2Neuronal pain pathway modulatorsAMBRON RICHARD·Filed 2007·Granted Sep 30, 2014·4 cites·1 claims
- 0778US9200265B2Anti-cocaine compositions and treatmentUNIV COLUMBIA·Filed 2012·Granted Dec 1, 2015·2 cites·19 claims
- 0878US8252754B2Neuronal pain pathwayAMBRON RICHARD·Filed 2006·Granted Aug 28, 2012·4 cites·9 claims
- 0972US8614222B2Methods of preventing and treating low bone mass diseasesKARSENTY GERARD·Filed 2009·Granted Dec 24, 2013·1 cites·4 claims
- 1070US11261199B2Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2020·Granted Mar 1, 2022·0 cites·14 claims
- 1169US2024408066A1Treatment Of Conditions Associated With Stress Granule FormationUNIV COLUMBIA·Filed 2024·Application pending·0 cites
- 1267US11230558B2Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2018·Granted Jan 25, 2022·0 cites·23 claims
- 1367US11008341B2Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2018·Granted May 18, 2021·0 cites·23 claims
- 1467US10865214B2Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2018·Granted Dec 15, 2020·0 cites·19 claims
- 1567US8653273B2Potent non-urea inhibitors of soluble epoxide hydrolaseRINDERSPACHER KIRSTEN ALISON·Filed 2011·Granted Feb 18, 2014·2 cites·14 claims
- 1663US10487091B2Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2017·Granted Nov 26, 2019·0 cites·13 claims
- 1763US8685963B2Compounds that inhibit NFκB and BACE1 activityLANDRY DONALD W·Filed 2011·Granted Apr 1, 2014·1 cites·4 claims
- 1860US7348403B2Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticidesUNIV COLUMBIA·Filed 2003·Granted Mar 25, 2008·2 cites·7 claims
- 1959US11459306B2Compounds, compositions, and methods for treating T-cell acute lymphoblastic leukemiaUNIV COLUMBIA·Filed 2018·Granted Oct 4, 2022·0 cites·28 claims
- 2058US9175285B2Potent non-urea inhibitors of soluble epdxide hydrolaseUNIV COLUMBIA·Filed 2014·Granted Nov 3, 2015·0 cites·10 claims
- 2157US2019112317A1Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2016·Application pending·0 cites
- 2257US2018305314A1Potent non-urea inhibitors of soluble epoxide hydrolaseUNIV COLUMBIA·Filed 2018·Application pending·0 cites
- 2355US2010152440A1NOVEL ANTI-ARRHYTHMIC AND HEART FAILURE DRUGS THAT TARGET THE LEAK IN THE RYANODINE RECEPTOR (RyR2)MARKS ANDREW ROBERT·Filed 2009·Application pending·0 cites
- 2455US2022251143A1Non-hydrolyzable non-cleavable, stable linkers for precision therapeutics and uses thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 2554US10882863B2Compounds for reducing c-Myc in c-Myc overexpressing cancers backgroundUNIV COLUMBIA·Filed 2017·Granted Jan 5, 2021·0 cites·19 claims
- 2653US10005732B2Potent non-urea inhibitors of soluble epoxide hydrolaseUNIV COLUMBIA·Filed 2015·Granted Jun 26, 2018·0 cites·12 claims
- 2753US9896420B2N-quinolin-benzensulfonamides and related compounds for the treatment of cancer, autoimmune disorders and inflammationUNIV COLUMBIA·Filed 2013·Granted Feb 20, 2018·0 cites·2 claims
- 2853US9107868B2Neuronal pain pathwayAMBRON RICHARD·Filed 2012·Granted Aug 18, 2015·0 cites·10 claims
- 2953US2018360842A1Histone Acetyltransferase Activators and Uses ThereofUNIV COLUMBIA·Filed 2018·Application pending·0 cites
- 3052US12168664B2Triazolopyrimidines, their preparation and usePETRUKHIN KONSTANTIN·Filed 2020·Granted Dec 17, 2024·0 cites·20 claims
- 3151US2015239831A1Inhibitors of central nervous system vasoactive inhibitory peptide receptor 2UNIV COLUMBIA·Filed 2015·Application pending·0 cites
- 3250US10485845B2Neuronal pain pathwayUNIV COLUMBIA·Filed 2015·Granted Nov 26, 2019·0 cites·3 claims
- 3350US10098975B2Labeled pkg-1-alpha-binding compounds and their use in imaging and quantifying painUNIV COLUMBIA·Filed 2015·Granted Oct 16, 2018·0 cites·4 claims
- 3449US2014275165A1COMPOUNDS THAT INHIBIT NFkB AND BACE1 ACTIVITYUNIV COLUMBIA·Filed 2014·Application pending·0 cites
- 3548US2016160195A1Anti-cocaine compositions and treatmentLANDRY DONALD·Filed 2015·Application pending·0 cites
- 3647US9981025B2Anti-drug vaccinesUNIV COLUMBIA·Filed 2015·Granted May 29, 2018·0 cites·7 claims
- 3746US2010204258A1Methods and compositions for modulating insulin secretion and glucose metabolismUNIV COLUMBIA·Filed 2008·Application pending·0 cites
- 3846US2022185797A1Selective foxo inhibitors for treatment of diabetes and other disorders related to impaired pancreatic functionTHE TRUSTEES OF COLUMBIA UNIV THE CITY OF NEW YORK·Filed 2020·Application pending·0 cites
- 3945US2004229781A1Compounds and methods for treating and preventing exercise-induced cardiac arrhythmiasFiled 2003·Application pending·0 cites
- 4043US2014336193A1Potent non-urea inhibitors of soluble epoxide hydrolaseUNIV COLUMBIA·Filed 2014·Application pending·0 cites
- 4143US2018118699A1Sk and ik channel agonists for treatment of heart failureUNIV COLUMBIA·Filed 2017·Application pending·0 cites
- 4241US9173874B2Anti-drug vaccinesDENG SHI-XIAN·Filed 2012·Granted Nov 3, 2015·0 cites·13 claims
- 4339US2011071124A1Compounds that Inhibit Production of sAPPB and AB and Uses ThereofUNIV COLUMBIA·Filed 2010·Application pending·0 cites
- 4436US2019070183A1Targeting Casein Kinase-1 and PI3K/AKT/mTOR Pathways for Treatment of c-Myc-Overexpressing Cancers, Organ Transplant Associated Complications and Autoimmune DiseasesUNIV COLUMBIA·Filed 2016·Application pending·0 cites
- 4532US8815883B2Compounds and methods for inhibiting serotonin synthesisLANDRY DONALD·Filed 2010·Granted Aug 26, 2014·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Shi-Xian Deng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →